Compare IDEXX Laboratories, Inc. (IDXX) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Western Union Co — how do they compare? IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B), while Western Union Co trades at $7.1 (market cap $2.20B). The key difference: IDEXX Laboratories, Inc. is far larger — about 21× Western Union Co's market cap, and Western Union Co pays a 13.33% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | WU | |
|---|---|---|
Market Cap | $46.22B | $2.20B |
Sector | Health | Technology |
52-Week High | $766.68 | $10.28 |
52-Week Low | $526.44 | $6.36 |
Enterprise Value | $47.12B | $2.10B |
Dividend Yield | — | 13.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Western Union (WU) trades at $7.13, up 1.42% with bearish technical signals and mixed fundamentals. The stock shows attractive valuation metrics with P/E of 5.69 and P/S of 0.56, but faces revenue decline from $4.5B in 2022 to $4.05B in 2025. Recent Q2 2026 earnings missed estimates at $0.31 vs. $0.42 expected, continuing a trend of earnings underperformance despite strong profitability margins.
The outlook remains challenging with declining revenue trends and bearish analyst sentiment (57% Hold, 31% Sell). Key risks include competitive pressure in money transfer services and digital transition challenges. The consensus price target of $7.14 offers minimal upside potential from current levels, suggesting limited near-term growth prospects for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
